SSB(SSB)
SSB
Q4 2026 EPS Estimate
$2.41
Oct 28, 2026 · Reports after close
Revenue Estimate
$690M
FY2026E EPS$9.48
FY2027E EPS$10.30
Analyst Sentiment
Wall St. Consensus
Buy20 analysts·High coverage
69
Score
14 Buy (70%)6 Hold (30%)0 Sell (0%)
Rating Breakdown
Strong Buy
15%
Buy
1365%
Hold
630%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$108.00
-3.2%
Consensus
$118.00
+5.7%
Bull
$125.00
+12.0%
12-Month Target Range20 analysts
$108.00$118.00$125.00
Current $111.59Consensus
Current Price
$111.59
Upside to Consensus
$6.41
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+6.58%
EPS+8.73%
FY2028
Rev+7.40%
EPS+12.33%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.73B | $2.91B | $3.12B |
| Low | $2.71B | $2.85B | $3.10B |
| High | $2.74B | $2.96B | $3.15B |
| EBITDA Avg | $998M | $1.06B | $1.14B |
| Low | $991M | $1.04B | $1.13B |
| High | $1.00B | $1.08B | $1.15B |
| EBIT Avg | $907M | $967M | $1.04B |
| Low | $901M | $947M | $1.03B |
| High | $911M | $984M | $1.05B |
| Net Income Avg | $957M | $1.04B | $1.16B |
| Low | $938M | $1.02B | $1.12B |
| High | $975M | $1.06B | $1.21B |
| EPS Avg | $9.48 | $10.30 | $11.57 |
| Low | $9.33 | $10.15 | $11.09 |
| High | $9.69 | $10.56 | $12.06 |
| Analysts (Rev / EPS) | 9 / 10 | 9 / 11 | 3 / 2 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $690M | $702M | $701M | $720M | $735M | $747M |
| Low | $684M | $699M | $695M | $714M | $730M | $741M |
| High | $695M | $708M | $707M | $726M | $742M | $753M |
| EBITDA Avg | $253M | $257M | $257M | $264M | $269M | $273M |
| Low | $250M | $256M | $255M | $262M | $267M | $271M |
| High | $254M | $259M | $259M | $266M | $272M | $276M |
| EBIT Avg | $230M | $233M | $233M | $240M | $245M | $249M |
| Low | $228M | $233M | $231M | $238M | $243M | $247M |
| High | $231M | $236M | $235M | $242M | $247M | $251M |
| Net Income Avg | $236M | $240M | $238M | $250M | $259M | $268M |
| Low | $232M | $231M | $236M | $248M | $256M | $265M |
| High | $240M | $247M | $241M | $253M | $262M | $270M |
| EPS Avg | $2.40 | $2.44 | $2.42 | $2.54 | $2.64 | $2.72 |
| Low | $2.36 | $2.35 | $2.40 | $2.52 | $2.61 | $2.69 |
| High | $2.45 | $2.51 | $2.45 | $2.57 | $2.66 | $2.75 |
| Analysts (Rev / EPS) | 8 / 9 | 8 / 9 | 4 / 6 | 5 / 3 | 4 / 3 | 5 / 6 |